Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation
Blood, 2013-05, Vol.121 (22), p.4575-4585
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Distinct Ldb1/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells
Blood, 2011-12, Vol.118 (23), p.6200-6208
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
New Concepts in Genome Regulation
Blood, 2016-12, Vol.128 (22), p.SCI-47-SCI-47
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Distinct Ldbl/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells
Blood, 2011, Vol.118 (23), p.6200-6208
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Heterozygous variants of CLPB are a cause of severe congenital neutropenia
Blood, 2022-02, Vol.139 (5), p.779-791
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Efficacy and Safety of CPX-351 Versus 7+3 in a Subgroup of Older Patients with Newly Diagnosed Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Enrolled in a Phase 3 Study
Blood, 2018-11, Vol.132 (Supplement 1), p.1425-1425
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
The Impact of Hematopoietic Cell Transplantation on Survival: An Exploratory Analysis of a Phase 3 Study of CPX-351 Versus 7+3 in Older Patients with Newly Diagnosed, High-Risk/Secondary AML
Blood, 2018-11, Vol.132 (Supplement 1), p.2706-2706
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Rates of Adverse Events per Patient-Year in a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes
Blood, 2017-12, Vol.130, p.1366-1366
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Efficacy and Safety of CPX-351 Versus 7+3 in Older Adults with Secondary Acute Myeloid Leukemia: Combined Subgroup Analysis of Phase 2 and Phase 3 Studies
Blood, 2017-12, Vol.130, p.2657-2657
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Survival Following Allogeneic Hematopoietic Cell Transplantation in Older High-Risk Acute Myeloid Leukemia Patients Initially Treated with CPX-351 Liposome Injection Versus Standard Cytarabine and Daunorubicin: Subgroup Analysis of a Large Phase III Trial
Blood, 2016-12, Vol.128 (22), p.906-906
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Analysis of Efficacy By Age for Patients Aged 60-75 with Untreated Secondary Acute Myeloid Leukemia (AML) Treated with CPX-351 Liposome Injection Versus Conventional Cytarabine and Daunorubicin in a Phase III Trial
Blood, 2016-12, Vol.128 (22), p.902-902
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A Novel SET Antagonist (OP449) Is Cytotoxic to CML Cells, Including the Highly-Resistant BCR-ABLT315I Mutant, and Demonstrates Enhanced Efficacy in Combination with ABL Tyrosine Kinase Inhibitors
Blood, 2011-11, Vol.118 (21), p.3757-3757
2011
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias
Blood, 2013-11, Vol.122 (21), p.2511-2511
2013
Volltextzugriff (PDF)
1 – 13 von 13
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieBlood
Suchergebnisse filtern
Filter anzeigen